GRANULES896.50

Granules India Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAUROPHARMAIPCALABAARTIDRUGSERISINDGNEMCUREJUBLPHARMACONCORDBIOMcap ₹22,215 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations4,506.44,481.65,365.65,632.3
Other Income4.412.920.36.3
Total Income4,510.84,494.55,386.05,638.6
Expenses
+ Cost of Materials Consumed2,208.21,724.92,099.82,167.1
+ Changes in Inventories-187.00.8-224.1-208.7
+ Employee Benefit Expense597.9659.8888.4940.2
+ Finance Costs105.8103.2114.4111.7
+ Depreciation & Amortisation207.3225.5296.1306.9
+ Other Expenses1,031.31,150.91,416.41,456.4
Total Expenses3,963.53,865.14,591.04,773.6
EBITDA856.0945.21,185.11,277.3
EBIT648.6719.7889.0970.4
Profit
PBT before Exceptional Items547.2629.4795.0864.9
+ Exceptional Items0.030.8-10.015.9
Pretax Income547.2660.2785.0880.9
+ Current Tax165.2182.8196.1222.6
+ Deferred Tax-23.3-24.2-6.2-4.1
Tax Expense141.9158.7190.0218.5
Net Income405.3501.5595.0662.3
+ Net Income — Continuing Ops405.3501.5595.0662.3
+ Other Comprehensive Income20.527.0143.3154.3
Total Comprehensive Income425.8528.5738.3816.7
Net Income to Common425.8501.5
Per Share
Basic EPS16.7320.6924.4727.06
Diluted EPS16.7220.6824.4626.92
Other Comprehensive Income — detail
+ Other Comprehensive Income27.0143.3154.3
+ Items NOT to be Reclassified to P&L-0.62.110.3
+ Tax on Items NOT to be Reclassified0.52.1
+ Tax on Items NOT to be Reclassified — alt tag-0.1
+ Items to be Reclassified to P&L23.926.3122.6141.9
+ Tax on Items to be Reclassified0.8-12.5-4.2
+ Tax on Items to be Reclassified — alt tag3.0
Comprehensive Income — Owners of Parent20.527.0
Per Share — as-filed variants
Basic EPS — Continuing Operations16.7320.6924.4727.06
Diluted EPS — Continuing Operations16.7220.6824.4626.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,485.12,755.93,489.93,673.9
Gross Margin %55.1561.4965.0465.23
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)547.2629.4795.0864.9
− Exceptional Items (reconciliation)0.030.8-10.015.9
Net Income Adj (tax-effected)405.3478.2602.6650.4
EPS Adj16.7319.7324.7826.57
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital24.224.324.824.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.